Jane Street’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,607
Closed -$423K 13181
2025
Q4
$414K Buy
4,607
+2,433
+112% +$231K ﹤0.01% 8119
2025
Q3
$214K Buy
+2,174
New +$215K ﹤0.01% 9548
2025
Q2
Sell
-2,318
Closed -$224K 11119
2025
Q1
$262K Sell
2,318
-213,038
-99% -$22.8M ﹤0.01% 8024
2024
Q4
$22.7M Buy
+215,356
New +$23.1M ﹤0.01% 1168
2024
Q3
Sell
-192,455
Closed -$21M 10536
2024
Q2
$20.9M Buy
192,455
+145,188
+307% +$17.1M ﹤0.01% 1284
2024
Q1
$6.24M Sell
47,267
-15,386
-25% -$1.92M ﹤0.01% 2335
2023
Q4
$7.62M Sell
62,653
-29,642
-32% -$3.31M ﹤0.01% 2294
2023
Q3
$10.4M Buy
92,295
+17,870
+24% +$2.27M ﹤0.01% 1732
2023
Q2
$10.8M Buy
74,425
+56,572
+317% +$7.69M ﹤0.01% 1820
2023
Q1
$2.31M Buy
17,853
+12,307
+222% +$1.55M ﹤0.01% 3573
2022
Q4
$707K Sell
5,546
-62,175
-92% -$7.22M ﹤0.01% 5563
2022
Q3
$7.08M Buy
67,721
+50,942
+304% +$5.59M ﹤0.01% 2111
2022
Q2
$1.76M Sell
16,779
-110,810
-87% -$13.1M ﹤0.01% 4396
2022
Q1
$16.3M Buy
127,589
+105,001
+465% +$12.7M 0.01% 1457
2021
Q4
$2.79M Buy
22,588
+10,513
+87% +$1.38M ﹤0.01% 3817
2021
Q3
$1.72M Sell
12,075
-47,580
-80% -$7M ﹤0.01% 4784
2021
Q2
$9.31M Buy
59,655
+15,738
+36% +$2.55M ﹤0.01% 1805
2021
Q1
$6.83M Buy
43,917
+26,225
+148% +$4.06M ﹤0.01% 1983
2020
Q4
$2.65M Sell
17,692
-1,550
-8% -$219K ﹤0.01% 3015
2020
Q3
$2.54M Sell
19,242
-24,877
-56% -$3.25M ﹤0.01% 2676
2020
Q2
$5.11M Buy
44,119
+20,242
+85% +$2.33M ﹤0.01% 1816
2020
Q1
$2.34M Buy
23,877
+17,152
+255% +$2.25M ﹤0.01% 1867
2019
Q4
$977K Sell
6,725
-1,798
-21% -$248K ﹤0.01% 2816
2019
Q3
$1.14M Sell
8,523
-36,229
-81% -$4.68M ﹤0.01% 2458
2019
Q2
$5.12M Buy
44,752
+34,248
+326% +$4.01M 0.01% 1032
2019
Q1
$1.3M Sell
10,504
-34,641
-77% -$3.94M ﹤0.01% 2508
2018
Q4
$4.55M Buy
45,145
+40,752
+928% +$4.58M 0.01% 1007
2018
Q3
$561K Sell
4,393
-12,896
-75% -$1.53M ﹤0.01% 3477
2018
Q2
$1.87M Buy
17,289
+4,051
+31% +$441K ﹤0.01% 2013
2018
Q1
$1.4M Buy
13,238
+10,385
+364% +$1.21M ﹤0.01% 2254
2017
Q4
$334K Buy
+2,853
New +$323K ﹤0.01% 3636
2017
Q3
Sell
-41,889
Closed -$4.84M 5180
2017
Q2
$5.22M Buy
+41,889
New +$4.97M 0.02% 748
2017
Q1
Sell
-51,426
Closed -$5.83M 4778
2016
Q4
$5.15M Buy
51,426
+39,514
+332% +$4.24M 0.02% 648
2016
Q3
$1.5M Sell
11,912
-104,349
-90% -$12.9M 0.01% 1498
2016
Q2
$13.6M Buy
116,261
+113,510
+4,126% +$12.8M 0.07% 252
2016
Q1
$285K Sell
2,751
-1,400
-34% -$135K ﹤0.01% 3275
2015
Q4
$413K Buy
+4,151
New +$406K ﹤0.01% 2708
2015
Q2
Sell
-4,587
Closed -$523K 4128
2015
Q1
$523K Buy
+4,587
New +$523K ﹤0.01% 2016
2014
Q3
Sell
-2,054
Closed -$207K 3143
2014
Q2
$207K Sell
2,054
-2,977
-59% -$290K ﹤0.01% 2176
2014
Q1
$462K Sell
5,031
-1,906
-27% -$176K 0.01% 1640
2013
Q4
$628K Buy
+6,937
New +$600K 0.01% 1064

Other funds holding ZBH

Jane Street's ZBH Position: Q1 2026 in Review

Jane Street sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 4,607 shares — an estimated $423K sold.

Jane Street first reported a position in ZBH in Q4 2013 and held it in 41 quarters. The position peaked at $22.7M in Q4 2024. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Jane Street reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 4,607 Zimmer Biomet shares in Q1 2026, an estimated $423K.
  • Jane Street first reported a position in Zimmer Biomet in Q4 2013 and held it in 41 quarters.
  • Jane Street's Zimmer Biomet position peaked at $22.7M in Q4 2024.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.